Alkem Laboratories Slumps After US FDA's Observations On Daman Plant

Shares of Alkem Laboratories slumped as much as 8.7 per cent today after the pharma company said it has received 13 observations about Daman plant from US FDA.  Alkem Laboratories said that the US regulator had conducted an inspection at the company's manufacturing facility located at Daman from September 20 to September 29, 2016.  Alkem Laboratories has received the inspection report which contains thirteen 483 observations, it sa...